BIOMAT Database Logo BIOMAT Database Logo

The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis. 1974

M Bielawiec, and M Myśliwiec, and A Perzanowski

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004492 Edetic Acid A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive. EDTA,Edathamil,Edetates,Ethylenediaminetetraacetic Acid,Tetracemate,Calcium Disodium Edetate,Calcium Disodium Versenate,Calcium Tetacine,Chelaton 3,Chromium EDTA,Copper EDTA,Coprin,Dicobalt EDTA,Disodium Calcitetracemate,Disodium EDTA,Disodium Ethylene Dinitrilotetraacetate,Distannous EDTA,Edetate Disodium Calcium,Edetic Acid, Calcium Salt,Edetic Acid, Calcium, Sodium Salt,Edetic Acid, Chromium Salt,Edetic Acid, Dipotassium Salt,Edetic Acid, Disodium Salt,Edetic Acid, Disodium Salt, Dihydrate,Edetic Acid, Disodium, Magnesium Salt,Edetic Acid, Disodium, Monopotassium Salt,Edetic Acid, Magnesium Salt,Edetic Acid, Monopotassium Salt,Edetic Acid, Monosodium Salt,Edetic Acid, Potassium Salt,Edetic Acid, Sodium Salt,Ethylene Dinitrilotetraacetate,Ethylenedinitrilotetraacetic Acid,Gallium EDTA,Magnesium Disodium EDTA,N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine),Potassium EDTA,Stannous EDTA,Versenate,Versene,Acid, Edetic,Acid, Ethylenediaminetetraacetic,Acid, Ethylenedinitrilotetraacetic,Calcitetracemate, Disodium,Dinitrilotetraacetate, Disodium Ethylene,Dinitrilotetraacetate, Ethylene,Disodium Versenate, Calcium,EDTA, Chromium,EDTA, Copper,EDTA, Dicobalt,EDTA, Disodium,EDTA, Distannous,EDTA, Gallium,EDTA, Magnesium Disodium,EDTA, Potassium,EDTA, Stannous,Edetate, Calcium Disodium,Ethylene Dinitrilotetraacetate, Disodium,Tetacine, Calcium,Versenate, Calcium Disodium

Related Publications

M Bielawiec, and M Myśliwiec, and A Perzanowski
The effect of intramuscular stanozolol on fibrinolysis and blood lipids.
October 1982, Thrombosis research,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Platelet survival and adhesiveness in recurrent venous thrombosis.
May 1973, The New England journal of medicine,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol or stanozolol.
March 1970, Lancet (London, England),
M Bielawiec, and M Myśliwiec, and A Perzanowski
Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
January 1972, Acta Universitatis Carolinae. Medica. Monographia,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Coagulation and platelet adhesiveness in recurrent "idiopathic" venous thrombosis.
January 1972, Acta chirurgica Scandinavica,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Increased platelet adhesiveness in recurrent venous thrombosis and pulmonary embolism.
October 1965, British medical journal,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Phenformin and ethyloestrenol in recurrent venous thrombosis.
January 1975, Acta medica Scandinavica,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Study of platelet adhesiveness and serum lipids in cerebral venous-venous sinus thrombosis during puerperium.
October 1970, The Journal of the Association of Physicians of India,
M Bielawiec, and M Myśliwiec, and A Perzanowski
Effect of oestriol on platelet adhesiveness and fibrinolysis in men.
October 1966, Lancet (London, England),
M Bielawiec, and M Myśliwiec, and A Perzanowski
Phenformin and stanozolol in blood fibrinolytic activity.
February 1970, British medical journal,
Copied contents to your clipboard!